Quasar passes FDA inspection with no 483 findings

An FDA inspection was conducted at the Quasar manufacturing facility in Shenzhen, October 31  to November 3, 2016.

This is the second consecutive FDA inspection Quasar passed with ZERO findings (no 483). This result endorses Quasar’s commitment to being a world-class medical device manufacturer.

Consistent with Quasar’s legacy of maintaining high quality standards, we focus on quality throughout the facility, whether in employee training, process development, equipment validations and all phases to manufacturing.

Guide
Sensor technology used in minimally invasive diagnostics
Sensor technology is at the forefront of minimally invasive diagnostics. The effectiveness of using sensor tipped catheters is their ability to be steered through the
Guide
Design Considerations of Electromagnetic sensors for Catheters
Catheters equipped with sensory technology such as electromagnetic sensing are an emerging technology that is extremely useful in 3D imaging for interventional cardiology procedures. The

Contact

How can we help?
GDPR*
This field is for validation purposes and should be left unchanged.